CAMKII as a therapeutic target for growth factor–induced retinal and choroidal neovascularization

While anti-VEGF drugs are commonly used to inhibit pathological retinal and choroidal neovascularization, not all patients respond in an optimal manner. Mechanisms underpinning resistance to anti‑VEGF therapy include the upregulation of other proangiogenic factors. Therefore, therapeutic strategies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Ashraf, Sadaf, Bell, Samuel, O’Leary, Caitriona, Canning, Paul, Micu, Ileana, Fernandez, Jose A., O’Hare, Michael, Barabas, Peter, McCauley, Hannah, Brazil, Derek P., Stitt, Alan W., McGeown, J. Graham, Curtis, Tim M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482993/
https://ncbi.nlm.nih.gov/pubmed/30721154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122442
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados